Fitzgerald Kevin Joseph
Insider CIK 1886431 · ALNY CSO & EVP, Head of Research · OVID Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. | A Award | 2026-04-07 | 2026-04-09 | 17,578 | $2.56 | $45.0K | 17,578 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 153 | $326.24 | $49.9K | 20,569 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 148 | $324.60 | $48.0K | 20,722 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 233 | $323.25 | $75.3K | 20,870 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 124 | $321.81 | $39.9K | 21,103 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 59 | $320.81 | $18.9K | 21,744 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 79 | $321.82 | $25.4K | 21,665 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 28 | $320.01 | $9.0K | 21,803 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 57 | $325.67 | $18.6K | 21,227 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 75 | $324.88 | $24.4K | 21,284 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 210 | $323.84 | $68.0K | 21,359 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 96 | $323.01 | $31.0K | 21,569 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 29 | $319.03 | $9.3K | 21,831 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 359 | $321.58 | $115.4K | 21,860 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 722 | $320.51 | $231.4K | 22,219 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 282 | $318.62 | $89.9K | 22,941 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 289 | $316.55 | $91.5K | 23,223 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-03-02 | 2026-03-04 | 8,105 | — | $0 | 8,105 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-03-02 | 2026-03-04 | 3,688 | — | $0 | 25,110 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 47 | $323.62 | $15.2K | 25,063 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 90 | $324.65 | $29.2K | 24,973 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 258 | $325.63 | $84.0K | 24,715 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 392 | $326.81 | $128.1K | 24,323 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 329 | $327.67 | $107.8K | 23,994 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 100 | $328.71 | $32.9K | 23,894 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 170 | $329.71 | $56.1K | 23,724 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 81 | $330.85 | $26.8K | 23,643 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 94 | $331.93 | $31.2K | 23,549 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 37 | $332.64 | $12.3K | 23,512 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-02-23 | 2026-02-25 | 158 | — | $0 | 21,422 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-17 | 2026-02-17 | 2,041 | $331.96 | $677.5K | 21,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-13 | 2026-02-17 | 1,959 | $310.08 | $607.4K | 23,305 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-02-12 | 2026-02-17 | 4,000 | — | $0 | 25,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-13 | 2026-01-14 | 280 | $372.93 | $104.4K | 21,386 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-13 | 2026-01-14 | 485 | $371.24 | $180.1K | 21,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-13 | 2026-01-14 | 644 | $370.00 | $238.3K | 22,151 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-13 | 2026-01-14 | 562 | $368.76 | $207.2K | 22,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-13 | 2026-01-14 | 197 | $367.52 | $72.4K | 23,357 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-13 | 2026-01-14 | 122 | $374.33 | $45.7K | 21,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 15 | $377.82 | $5.7K | 23,554 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 19 | $375.65 | $7.1K | 23,569 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 14 | $374.44 | $5.2K | 23,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 2 | $372.46 | $745 | 23,602 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 19 | $370.87 | $7.0K | 23,604 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 40 | $369.48 | $14.8K | 23,623 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 92 | $368.62 | $33.9K | 23,663 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 41 | $367.40 | $15.1K | 23,755 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 50 | $366.41 | $18.3K | 23,796 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 220 | $365.56 | $80.4K | 23,846 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 199 | $364.83 | $72.6K | 24,066 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 47 | $363.55 | $17.1K | 24,265 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 73 | $362.38 | $26.5K | 24,312 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 98 | $361.45 | $35.4K | 24,385 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 155 | $360.22 | $55.8K | 24,483 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 85 | $359.14 | $30.5K | 24,638 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 123 | $358.18 | $44.1K | 24,723 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 96 | $357.17 | $34.3K | 24,846 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 41 | $356.09 | $14.6K | 24,942 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 42 | $355.16 | $14.9K | 24,983 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 39 | $353.95 | $13.8K | 25,025 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-01-11 | 2026-01-14 | 3,800 | — | $0 | 25,064 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-17 | 2025-11-19 | 8,161 | — | $0 | 839 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 295 | $463.08 | $136.6K | 21,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 323 | $461.96 | $149.2K | 21,559 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-17 | 2025-11-19 | 8,161 | $119.13 | $972.2K | 33,392 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 8,168 | $449.00 | $3.67M | 25,224 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 707 | $460.84 | $325.8K | 21,882 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 622 | $459.89 | $286.1K | 22,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 794 | $458.41 | $364.0K | 23,211 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 262 | $457.39 | $119.8K | 24,005 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 364 | $456.25 | $166.1K | 24,267 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 368 | $455.24 | $167.5K | 24,631 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 129 | $451.51 | $58.2K | 24,999 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-17 | 2025-11-19 | 96 | $450.09 | $43.2K | 25,128 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 122 | $457.43 | $55.8K | 25,234 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 203 | $454.84 | $92.3K | 25,416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 60 | $455.82 | $27.3K | 25,356 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 273 | $453.77 | $123.9K | 25,619 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 3 | $457.64 | $1.4K | 25,231 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 96 | $446.53 | $42.9K | 27,576 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 47 | $447.92 | $21.1K | 27,529 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 150 | $448.77 | $67.3K | 27,379 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 207 | $449.79 | $93.1K | 27,172 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 449 | $450.81 | $202.4K | 26,723 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 276 | $451.86 | $124.7K | 26,447 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 555 | $452.69 | $251.2K | 25,892 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 2,102 | — | $0 | 24,821 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 2,851 | — | $0 | 27,672 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 543 | $454.04 | $246.5K | 22,972 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 329 | $452.96 | $149.0K | 23,515 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 103 | $451.99 | $46.6K | 23,844 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 12 | $455.82 | $5.5K | 22,719 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 90 | $449.92 | $40.5K | 23,986 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 39 | $447.98 | $17.5K | 24,076 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 241 | $454.84 | $109.6K | 22,731 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 39 | $450.92 | $17.6K | 23,947 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-08-15 | 2025-08-19 | 2,851 | — | $0 | 24,115 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-07-01 | 2025-07-02 | 7,763 | — | $0 | 21,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 328 | $240.95 | $79.0K | 13,896 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 71 | $242.93 | $17.2K | 13,501 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 121 | $239.24 | $28.9K | 14,224 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 324 | $241.68 | $78.3K | 13,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-03-03 | 2025-03-05 | 7,819 | — | $0 | 7,819 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-03-03 | 2025-03-05 | 3,871 | — | $0 | 16,256 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 204 | $242.37 | $49.4K | 16,052 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 224 | $243.36 | $54.5K | 15,828 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 151 | $244.41 | $36.9K | 15,677 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 111 | $245.26 | $27.2K | 15,566 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 45 | $246.18 | $11.1K | 15,521 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 4 | $247.35 | $989 | 15,517 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 1 | $248.36 | $248 | 15,516 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 465 | $242.69 | $112.9K | 15,051 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 487 | $243.94 | $118.8K | 14,564 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 219 | $245.30 | $53.7K | 14,345 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 21 | $238.33 | $5.0K | 12,833 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 27 | $236.51 | $6.4K | 12,854 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 75 | $243.23 | $18.2K | 12,422 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 37 | $244.11 | $9.0K | 12,385 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 187 | $242.44 | $45.3K | 12,497 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 79 | $241.51 | $19.1K | 12,684 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 48 | $240.32 | $11.5K | 12,763 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 22 | $239.18 | $5.3K | 12,811 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2025-02-20 | 2025-06-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 76 | $257.79 | $19.6K | 12,964 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 83 | $259.10 | $21.5K | 12,881 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 80 | $256.05 | $20.5K | 13,040 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 115 | $251.60 | $28.9K | 13,120 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 1,086 | $250.21 | $271.7K | 13,235 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 145 | $252.50 | $36.6K | 14,839 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 164 | $253.37 | $41.6K | 14,675 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 110 | $254.35 | $28.0K | 14,565 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 47 | $255.56 | $12.0K | 14,518 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 53 | $256.29 | $13.6K | 14,465 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 26 | $257.51 | $6.7K | 14,439 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 33 | $258.07 | $8.5K | 14,406 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 14 | $264.87 | $3.7K | 14,321 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 12 | $263.33 | $3.2K | 14,335 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 26 | $261.45 | $6.8K | 14,347 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 21 | $260.57 | $5.5K | 14,373 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 12 | $259.72 | $3.1K | 14,394 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-02-13 | 2025-02-18 | 2,103 | — | $0 | 14,984 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-12-12 | 2024-12-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-27 | 2024-11-27 | 210 | $250.45 | $52.6K | 14,202 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-27 | 2024-11-27 | 110 | $254.48 | $28.0K | 12,881 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-27 | 2024-11-27 | 360 | $253.44 | $91.2K | 12,991 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-27 | 2024-11-27 | 851 | $251.98 | $214.4K | 13,351 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 26 | $247.77 | $6.4K | 15,855 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 215 | $249.60 | $53.7K | 15,640 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 318 | $250.68 | $79.7K | 15,322 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 826 | $251.42 | $207.7K | 14,496 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 84 | $252.27 | $21.2K | 14,412 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-11-25 | 2024-11-27 | 3,000 | — | $0 | 15,881 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-08-12 | 2024-08-14 | 14,058 | — | $0 | 2,192 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-08-12 | 2024-08-14 | 6,667 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-12 | 2024-08-14 | 1,158 | $273.73 | $317.0K | 13,016 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-08-12 | 2024-08-14 | 14,058 | $85.00 | $1.19M | 34,906 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-08-12 | 2024-08-14 | 6,667 | $97.72 | $651.5K | 20,848 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-12 | 2024-08-14 | 135 | $274.65 | $37.1K | 12,881 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-12 | 2024-08-14 | 1,421 | $268.66 | $381.8K | 33,485 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-12 | 2024-08-14 | 3,913 | $272.43 | $1.07M | 14,174 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-12 | 2024-08-14 | 5,736 | $271.32 | $1.56M | 18,087 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-12 | 2024-08-14 | 9,662 | $270.17 | $2.61M | 23,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 45 | $221.71 | $10.0K | 15,334 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 9 | $224.17 | $2.0K | 15,325 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 13 | $225.55 | $2.9K | 15,312 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 26 | $226.82 | $5.9K | 15,286 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 96 | $228.30 | $21.9K | 15,190 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 198 | $229.06 | $45.4K | 14,992 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 227 | $229.93 | $52.2K | 14,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 74 | $231.59 | $17.1K | 14,691 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 125 | $235.19 | $29.4K | 14,181 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 138 | $234.66 | $32.4K | 14,306 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 86 | $233.53 | $20.1K | 14,444 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 161 | $232.54 | $37.4K | 14,530 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-06-24 | 2024-06-26 | 2,498 | — | $0 | 15,379 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-02-03 | 2022-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2021-10-06 | 2021-10-07 | 30,000 | — | $0 | 30,000 | SEC↗ |